Fuel for Recovery: Predicting G-Tube Dependence in HPV-Negative Operable HNSCC.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40799173.
- Also identified by DOI 10.1002/hed.70015 and PMC identifier 12703559.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
HPV-negative head and neck squamous cell carcinoma (HNSCC) patients can face prolonged gastrostomy tube (g-tube) dependence, affecting quality of life and delaying treatment. Existing models lack key health metrics like sarcopenia; this study develops a risk model to enhance preoperative assessment. This study analyzed 265 HNSCC patients. Sarcopenia was assessed via cervical paraspinal skeletal muscle mass (C3) on CT scans. Patients requiring g-tube support > 28 days were identified. Risk models were developed and compared to the PEG Score. A 50-patient validation cohort assessed model performance. Key predictors included male sex, sarcopenia, prior radiotherapy, and adjuvant therapy. Logistic regression (LR) model had the highest AUC (0.78); followed by Recursive Partitioning analysis (RPA) model (0.76), both outperforming the PEG Score (0.67). RPA model maintained superior accuracy in validation (AUC = 0.79). RPA model outperformed PEG Score, offering a more precise risk tool for preoperative planning and early intervention.
Medical subject headings
- Gastrostomy
- Sarcopenia
- Head and Neck Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Enteral Nutrition